In this research three series of substituted 1H-pyrazolo [3,4-b]pyridine phosphoramidates were synthesized and characterized by infrared, 1 H, 13 C, and 31 P nuclear magnetic resonance (NMR) spectroscopy and high-resolution mass spectrometry. The products were obtained in good yields (67-83%) under mild conditions by nucleophilic aromatic substitution reaction of aminoalkylphosphoramidates over 4-chloro-1H-pyrazolo[3,4-b]pyridines. These compounds were evaluated as antileishmanials against Leishmania amazonensis promastigotes in vitro. Among all, compounds of a series showed expressive antileishmanial activity. Two of them emerged as the most active, with IC 50 values of 6.44 ± 1.49 and 12.25 ± 0.68 µM. The cytotoxicity of this series was assessed on murine cells and presented values similar to the reference drug pentamidine.
Introduction
Leishmaniasis is caused by the protozoan Leishmania parasites which are transmitted by the bite of infected female phlebotomine sandflies. The disease affects some of the poorest people on earth, and is associated with malnutrition, population displacement, poor housing, a weak immune system and lack of financial resources. An estimated 900,000-1.3 million new cases and 20,000 to 30,000 deaths occur annually. 1 In the Americas, different dermotropic species that can affect humans are known and Leishmania amazonensis is associated with different forms of the disease, including cutaneous, hyperergic mucocutaneous, and the anergic diffuse cutaneous leishmaniasis. 2 Leishmania amazonensis is an important epidemiological species responsible for causing the most common cutaneous form of the disease and is also able to cause mucosal and visceral forms of leishmaniasis. 3 The recommended treatment for leishmaniasis is pentavalent antimony; however, this drug is toxic, causes many side effects and gives rise to drug-resistant parasites when used in high doses, requiring the use of second-line drugs, such as pentamidine and amphotericin B, which are even more toxic. Even with the use of second-line drugs, parasite survival and resistance still occurs. 4 Miltefosine, an alkyl phospholipid, has emerged as an effective drug against visceral leishmaniasis and was incorporated into the therapeutic routine in South Asia (India, Nepal and Bangladesh). According to the World Health Organization (WHO), strategies to improve leishmaniasis therapy include the search for new drugs, repurposing of existing drugs and combination therapy. 5 Several reports regarding natural and synthetic new antileishmanial compounds have been described and among them, there are the pyrazolopyridine derivatives, which have been revealed as potential new drugs against Leishmania infection. 2, 6, 7 1H-Pyrazolo [3,4-b] pyridine is an example of fused system, which is known to possess remarkable and significant biological and medicinal importance. 2, [8] [9] [10] [11] Fused heterocyclic systems containing pyrazole ring are ranked among the most versatile bioactive compounds, and a variety of procedures have been developed for their synthesis. [12] [13] [14] [15] In the past few years, we focused our efforts on the preparation of bioactive heterocycles containing phosphoramidate groups. [16] [17] [18] Introduction of a phosphoramidate group essentially changes the physical and chemical properties of the parent molecule, accentuating the polarization and intermolecular bonding characteristics. 19, 20 The P=O group plays a significant role as a strong hydrogen bond acceptor, which is essential for the noncovalent bonding of proteins or other specific ligands to their substrates. 21 The incorporation of a phosphoramidate group into different heterocyclic systems constitutes an interesting synthetic strategy used in the discovery of new drugs. 22 As part of the program in the rational search for new leishmanicide drugs with greater efficacy and lower toxicity, our laboratory is working on the study of the structure-activity relationship of synthetic compounds. Taking in account the molecular hybridization to improve the pharmacological properties, a series of new 1H-pyrazolo [3,4-b] pyridine phosphoramidate has been synthesized in our late research. Our research group reported the synthesis of various substances of pyrazole and pyrazolopyridine systems that showed antileishmania activity. A series of 4-arylamino-1H-pyrazolo [3,4-b] pyridine showed antileishmanial activity at micromolar concentrations. 2, [23] [24] [25] [26] Based on isosteric and group substitutions approaches and development of new drugs that are able to act as multitarget ligands, [27] [28] [29] we report the synthesis of fifteen new 1H-pyrazolo [3,4-b] pyridine phosphoramidates in search of new compounds with promising biological properties against L. amazonensis (Figure 1 ).
Results and Discussion

Synthesis
The synthetic pathway for the 1H-pyrazolo [3,4-b] pyridine phosphoramidates (14a-e, 15a-e and 16a-e) was successfully adapted from our previous research 30 and is shown in Schemes 1 and 2.
The intermediate ethyl 4-chloro-1-phenyl-1H-pyrazolo[3,4-b]pyridine-5-carboxylate (10a), ethyl 5-amino-1-phenyl-1H-pyrazole-4-carboxylate (5) could easily be prepared in 70% yield from the reaction of phenylhydrazine (1) and ethyl 2-cyano-3-ethoxyacrylate (2), in ethanol under reflux. The decarboxylated derivative 5-amino-1-phenyl-1H-pyrazol (6a) was obtained in 80% yield upon treatment of (5) with phosphoric acid (85%) at 170 °C. The Michael addition of 5-aminopyrazole (6a) with diethyl 2-(ethoxymethylene)malonate (7a) in ethanol under reflux afforded the 2-(((1-phenyl-1H-pyrazol-5-yl)amino)methylene)malonate (8a) in 85% yield, which was converted to (10a) in 75% yield with phosphorous oxychloride under reflux.
2,11 The 4-chloropyrazolopyridines 10b,c were synthesized from β-aminocrotononitrile (3) and benzoylacetonitrile (4) in a similar sequence.
2,9 Reaction of 5-aminopyrazoles (6b,c) with ethyl 2-cyano-3-ethoxyacrylate (7b) in ethanol under reflux afforded the derivatives 8b,c in 85 and 72% yield, respectively. Cyclization of pyrazoles (8b,c) was performed by refluxing dowtherm at 250 °C for 40 min and the products isolated by precipitation from hexane in 83% (9a) and 79% (9b) yield. These derivatives were refluxed with phosphorous oxychloride to produce (10b,c) in 62 and 73% yield, respectively.
The aminoalkylphosphoramidates (13a-e) were synthesized from diisopropylphosphonate (11) and aliphatic diamines (12a-e) according to Scheme 2. In order to guarantee monophosphorylation of the diamines, at least 2.5-fold excess of diamine in ethanol were used. Keeping alkaline pH and temperature below 55 °C is required to avoid bis-phosphorylation. 31 Nucleophilic aromatic substitution by amines has been used as a versatile route to new pyrazolopyridine derivatives. 2, 8, 32, 33 An halogen atom such as chlorine in the C-4 position as the leaving group and an ester or cyano group in the C-5 position as the withdrawing group propitiate the 1H-pyrazolo [3,4- with excess of the aminoalkylphosphoramidates (13a-e) in THF at 90 °C to obtain three series of substituted 1H-pyrazolo [3,4-b] pyridine phosphoramidates (14a-e, 15a-e and 16a-e) as solids in 67-83% yield (Scheme 2).
All the synthesized compounds were fully characterized by infrared, 1 H, 13 C, and 31 P nuclear magnetic resonance (NMR) spectroscopy and high-resolution mass spectrometry. J PH ca. 7.0 Hz. In the aliphatic region, the unequivocal assignment of the signals for methylene protons was based on COSY (correlation spectroscopy) correlations. The methyl protons signal for compounds 15a-e showed as a singlet at 2.69-2.80 ppm. Compounds 16a-e showed signals characteristic for aromatic protons of the phenyl groups around 6.94-8.11 ppm. Typically, the methyne J PC was observed. The 1H-pyrazolo [3,4-b] pyridine phosphoramidates 14a-e, 15a-e and 16a-e showed in their decoupled 31 P NMR spectra one signal in the region between 6.93-7.71 ppm, typical for phosphoramidates. [16] [17] [18] 30, 31, 34 Furthermore, infrared spectra exhibited strong absorptions for the P=O at 1249-1188 cm -1 , P−O around 1004-972 cm -1 , absorptions for the carbonyl group at 1683-1673 cm -1 for 14a-e and absorptions for the nitrile group at 2217-2204 cm -1 for 15a-e and 16a-e. In the 3429-3193 cm -1 region, NH bands were observed.
Antileishmanial activity
For the antileishmanial assays, the 50% growth inhibitory activity value, IC 50 , of each compound was determined using L. amazonensis, in promastigotes evolutive forms (MHOM / BR / 77LTB 0016). The IC 50 values were determined by linear regression, relating the inhibition percentage and the drug concentration in µM, as shown in Table 1 . The results indicate that among the three series 14, 15 and 16 assayed, compounds containing phenyl substituent at position R 1 of the pyrazole ring (16) were found to be the most active against promastigote forms presenting IC 50 in the range of 6-42 µM. These results observed in series 16 suggest an important role of the phenyl group (R 1 ) for leishmanicidal activity. The compound 16a, with the best growth inhibitory activity (IC 50 = 6.44 ± 1.49 µM), possess n = 2 (shorter aliphatic chain) whereas 16e, with n = 6 (longer aliphatic chain), presents IC 50 = 12.25 ± 0.68 µM. Interestingly, we observed that spacer length (n) in the three series does not appear to be the major factor that influences growth inhibition of promastigote. The cytotoxicity responses (CC 50 ) of derivatives 16 were assayed on the mice's peritoneal macrophages. The compounds 16a-e present the SI (selectivity index) values similar to the reference drug pentamidine.
Concerning the cyano derivatives, series 15a-e (R 1 = methyl), the most active compound was 15e (IC 50 = 9.81 ± 3.10 µM) with n = 6, followed by 15d (IC 50 = 18.89 ± 2.68 µM) with n = 5. Except for 15a in this series, we can observe an increase of antileishmanial activity with the augment of alkyl chain length, in agreement with literature. 35 Meanwhile, the compounds with R 2 = COOEt of series 14 (R 1 = H) exhibit lower IC 50 compared to series 15 and 16 with a cyano group as R 2 . In minor extent, methyl group (R 1 in series 15) may have also contributed to the antileishmanial activity.
Based in the data regarding activities of the three series, it was chosen to realize the cytotoxicity assay only with the most active series, 16a-e ( Table 2 ). The cytotoxicity analyses (CC 50 ) of those derivatives were carried out on peritoneal macrophages from BALB/c mice. The selectivity index (SI), which compare the activity of the compounds on the parasite and on the host cell (macrophages), showed that those compounds 16a and 16e present the best results (Table 2) , being similar to the values of the reference drug, pentamidine.
Conclusions
In summary, 15 new 1H-pyrazolo [3,4-b] pyridine phosphoramidate derivatives (14a-e, 15a-e and 16a-e) with different substituents were synthesized in order to evaluate their antileishmanial potential. We have proven that the molecular hybridization involving pyrazolopyridine and phosphoramide moieties is an important strategy to prepare new bioactive molecules. The compounds (20 × 20 cm) . Infrared spectra were recorded on a PerkinElmer Spectrum One FT-IR spectrometer. High resolution mass spectrometry (HRMS) spectra were measured using a LC/MSD-TOF Agilent Technologies instrument. The remaining reagents and solvents that were used were of analytical grade. The Cl-substituted pyrazolo [3,4-b] pyridine (10a-c) 2,33,36 and aminoalkylphosphoramidates (13a-e) 31 compounds were prepared as previously reported.
Synthesis
General procedure for 1H-pyrazolo [3,4-b] pyridine phosphoramidates derivatives (14a-e, 15a-e and 16a-e)
Cl-Substituted pyrazolo [3,4-b] pyridine (10a-c) (2.2 mmol) and the aminoalkylphosphoramidate (13a-e) (4.4 mmol) were dissolved in THF (10 mL) and the reaction mixture was heated at reflux until the disappearance of the starting (10a-c) ( 45 (m, 4H), 1.49-1.54 (m, 2H) L. amazonensis promastigotes in late log-phase in Schneider's medium supplemented with 10% fetal calf serum (FCS), 2 mM L-glutamine and antibiotics (100 U mL -1 penicillin and 100 µg mL -1 streptomycin), were incubated at an average density of 10 7 parasites mL -1 in sterile 96-well plates. Compounds to be assayed were added to the culture in a concentration range of 160-1.25 µg mL -1 dissolved in DMSO (final concentration less than 0.8% v/v). The assay was carried out in triplicate. Appropriate controls containing DMSO and pentamidine (reference drug) were added to each set of experiments. Parasite viability was assessed by a dye-reduction assay employing 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) and the absorbance measured in a spectrophotometer at 570 nm. 37 Growth inhibitory concentration 50% (IC 50 ) was defined as the concentration of drug required to inhibit by 50% the metabolic activity of Leishmania promastigotes compared to the control. IC 50 / 24 h were calculated by non-linear regression analysis processed on dose-response curves, using GraphPad Prism 5.0. IC 50 values represent the mean value calculated from three independent experiments.
Cytotoxic assays on murine peritoneal macrophages
Cytotoxicity was assessed on murine peritoneal macrophages of BALB/c mice by a colorimetric assay based on the mitochondrial reduction in MTT as described previously. 37 The cells were isolated from peritoneal cavity of mice with cold RPMI 1640 medium, supplemented with 10% FCS. The 2 × 10 6 cells well -1 were added to microplate and incubated at 37 °C in a humidified 5% CO 2 atmosphere. After 2 h of incubation, no adherent cells were removed and the adhered macrophages were washed with RPMI. Compounds were solubilized in DMSO at concentrations ranging from 320 to 2.5 µg mL -1 and added to the cell culture for 72 h of incubation at 37 °C and 5% CO 2 . After that, culture supernatant was removed. The macrophage viability was measured by adding MTT (0.5 mg mL -1 in PBS, 200 µL well -1 ), incubating plates for 2 h at 37 °C, and the colored product formazan was solubilized with DMSO. The results were read in spectrophotometer with wavelength of 570 nm. 37 
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